Edition:
India

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

82.79EUR
17 Nov 2017
Change (% chg)

€-0.65 (-0.78%)
Prev Close
€83.44
Open
€83.26
Day's High
€83.55
Day's Low
€82.78
Volume
622,988
Avg. Vol
541,634
52-wk High
€89.22
52-wk Low
€71.49

Select another date:

Thu, Nov 2 2017

Fresenius adj EBIT up 11 pct on hospitals, drugs

FRANKFURT, Nov 2 German healthcare group Fresenius said third-quarter adjusted net income gained 11 percent on higher drug sales and helped by the addition of Spanish hospitals chain Quironsalud.

BRIEF-FMC Q3 impacted by natural disasters in North America

* ‍Says Q3 sales up 3 pct at ‍4.336​ billion eur (+8 pct at constant currency)

BRIEF-NXSTAGE SAYS STOCKHOLDER APPROVE MERGER WITH FRESENIUS MEDICAL CARE

* NXSTAGE ANNOUNCES STOCKHOLDER APPROVAL OF MERGER AGREEMENT WITH FRESENIUS MEDICAL CARE

BRIEF-Quest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical Care

* Quest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical Care

BRIEF-Eurotech wins order from Fresenius Medical Care for IoT project​

* ‍DESIGN WIN WITH FRESENIUS MEDICAL CARE TO SUPPLY HARDWARE AND SOFTWARE BUILDING BLOCKS FOR THEIR IOT PROJECT​

BRIEF-NxStage Medical says if merger terminated, Fresenius Medical Care Holdings to pay termination fee of $100 mln- SEC Filing

* NxStage Medical - if merger agreement terminated under certain circumstances,Fresenius Medical Care Holdings to pay co a termination fee of $100 million Source text: (http://bit.ly/2ujNeVi) Further company coverage:

Deals of the day-Mergers and acquisitions

Aug 7 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

Fresenius Medical banks on home dialysis with $2 billion NxStage acquisition

FRANKFURT Germany's Fresenius Medical Care (FMC) has struck a $2 billion deal to acquire U.S. home dialysis equipment maker NxStage Medical Inc , looking to capitalize on a trend for more patients to opt for domestic treatment.

UPDATE 1-Dialysis provider FMC's Q2 profit misses consensus as costs weigh

* Profit at parent Fresenius jumps on new drug launches (Adds company comment on costs, premarket shares, parent Fresenius)

Dialysis provider FMC's Q2 profit edges up 2 pct as costs weigh

FRANKFURT, Aug 1 Fresenius Medical Care , the world's largest provider of kidney dialysis, posted a 2 percent gain in quarterly operating profit, missing consensus, as growth in the number of dialysis patients was offset by higher personnel expenses and other costs.

Select another date: